Birdwatch Note
2024-10-22 19:15:19 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
投稿者は医師ですが、知識不足(特に英語)で誤解を招いている可能性が高く注意が必要です。 タイトルをそのまんま訳すと 「ハイブリッドVEEV-狂犬病レプリコン由来の感染性増殖粒子に基づく新しい狂犬病ワクチン」 であり、 「レプリコンが感染性、増殖性粒子を作る」などと一言も書かれていません。 https://pubmed.ncbi.nlm.nih.gov/32512518/
Written by 4C5727E6D42A645A786101FD922065EE1C4C070F47A57F8F4FA90C597F3624FC
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1848708835894300933
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1848805350767792152
- noteId - 1848805350767792152
- participantId -
- noteAuthorParticipantId - 4C5727E6D42A645A786101FD922065EE1C4C070F47A57F8F4FA90C597F3624FC
- createdAtMillis - 1729624519422
- tweetId - 1848708835894300933
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 投稿者は医師ですが、知識不足(特に英語)で誤解を招いている可能性が高く注意が必要です。 タイトルをそのまんま訳すと 「ハイブリッドVEEV-狂犬病レプリコン由来の感染性増殖粒子に基づく新しい狂犬病ワクチン」 であり、 「レプリコンが感染性、増殖性粒子を作る」などと一言も書かれていません。 https://pubmed.ncbi.nlm.nih.gov/32512518/
Note Ratings
| rated at | rated by | |
| 2024-10-22 22:59:05 -0500 | Rating Details | |
| 2024-10-22 17:38:10 -0500 | Rating Details | |
| 2024-10-22 16:47:27 -0500 | Rating Details | |
| 2024-10-22 22:06:32 -0500 | Rating Details | |
| 2024-10-22 18:40:03 -0500 | Rating Details | |
| 2024-10-22 17:42:26 -0500 | Rating Details | |
| 2024-10-22 15:02:24 -0500 | Rating Details | |
| 2024-10-23 18:02:08 -0500 | Rating Details | |
| 2024-10-22 21:17:50 -0500 | Rating Details | |
| 2024-10-22 19:19:49 -0500 | Rating Details | |
| 2024-10-22 18:17:55 -0500 | Rating Details | |
| 2024-10-22 18:09:26 -0500 | Rating Details | |
| 2024-10-22 17:35:14 -0500 | Rating Details | |
| 2024-10-22 17:14:28 -0500 | Rating Details | |
| 2024-10-22 15:40:54 -0500 | Rating Details | |
| 2024-10-27 00:38:50 -0500 | Rating Details | |
| 2024-10-22 22:17:53 -0500 | Rating Details | |
| 2024-10-22 18:19:42 -0500 | Rating Details | |
| 2024-10-22 20:29:41 -0500 | Rating Details | |
| 2024-10-22 19:26:09 -0500 | Rating Details | |
| 2024-10-22 18:22:22 -0500 | Rating Details | |
| 2024-10-22 18:15:07 -0500 | Rating Details | |
| 2024-10-22 17:30:18 -0500 | Rating Details | |
| 2024-10-22 17:08:27 -0500 | Rating Details | |
| 2024-10-22 15:57:59 -0500 | Rating Details |